Fibrogen, inc. (FGEN)
Income statement / Yearly
Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13
Revenue:
Collaboration services and other revenue (includes $1,578, $1,357 and $2,895 from a related party)

-

-

-

-

32,735

20,410

7,209

Total revenue

256,577

212,958

130,996

183,189

180,828

137,601

102,170

Operating costs and expenses:
Cost of goods sold

1,147

0

0

-

-

-

-

Research and development

209,265

235,839

196,517

187,206

214,089

150,794

85,710

Selling, general and administrative

135,479

63,812

51,760

46,025

44,364

36,909

24,409

Total operating costs and expenses

345,891

299,651

248,277

233,231

258,453

187,703

110,119

Loss from operations

-89,314

-86,693

-117,281

-50,042

-77,625

-50,102

-7,949

Interest and other, net
Interest expense

2,876

10,991

9,706

10,725

11,033

11,108

10,702

Interest income and other, net

15,548

11,568

6,433

2,628

3,121

1,706

3,708

Total interest and other, net

12,672

577

-3,273

-8,097

-7,912

-9,402

-6,994

Loss before income taxes

-76,642

-86,116

-120,554

-58,139

-85,537

-59,504

-14,943

Benefit from income taxes

328

304

321

-71

242

0

0

Net loss

-76,970

-86,420

-120,875

-58,068

-85,779

-59,504

-14,943

Net loss per share - basic and diluted

-0.89

-1.03

-1.66

-0.93

-1.42

-3.17

-1.13

Weighted average number of common shares used to calculate net loss per share - basic and diluted

86,633

84,062

72,987

62,744

60,337

18,775

13,186

License Revenue [Member]
Total revenue

177,086

22,269

9,933

50,607

148,093

117,191

94,961

Development and Other Revenue [Member]
Total revenue

114,115

125,913

121,063

132,582

-

-

-

Product Revenue, Net [Member]
Total revenue

-34,624

64,776

0

0

-

-

-